Kenvue Inc. Reports Fiscal Year 2025 Results with $15.124 Billion in Net Sales and $1.470 Billion Net Income

Kenvue Inc. (KVUE) reported its fiscal year 2025 financial results, showcasing a net sales figure of $15.124 billion, a decrease of 2.1% compared to the $15.455 billion reported in fiscal year 2024. The company attributed this decline primarily to volume-related decreases of 2.3%, which were partially offset by favorable value realization of 0.1%. Despite the dip in sales, Kenvue's net income saw a significant increase, reaching $1.470 billion, a 42.7% surge from the $1.030 billion reported in the previous fiscal year. This boost in profitability was supported by a reduction in selling, general, and administrative expenses, as well as a substantial decrease in impairment charges.

Strategic developments during the year included a comprehensive review of strategic alternatives, which ultimately led to a merger agreement with Kimberly-Clark Corporation (K-C). The proposed transaction, valued at a combination of stock and cash, is expected to close in the second half of 2026, pending regulatory approvals and customary closing conditions. Kenvue's shareholders approved the adoption of the Merger Agreement on January 29, 2026. The company also continued its focus on innovation and digital strategy, aiming to enhance consumer engagement and drive growth across its brand portfolio.

Operationally, Kenvue faced challenges including trade inventory reductions driven by retailer inventory management in the United States and changes in shipment timing in China. These factors impacted volume across its Self Care, Skin Health and Beauty, and Essential Health segments. The company also navigated inflationary pressures and supply chain disruptions, implementing pricing actions and supply chain optimization initiatives to mitigate the impact on profitability. As of December 28, 2025, Kenvue employed approximately 22,000 individuals across its global operations, with a significant portion located in North America, EMEA, and APAC.

Looking ahead, Kenvue anticipates continued investments in its brands and digital capabilities to drive sustainable growth. However, the company acknowledges potential risks and uncertainties, including those related to the proposed transaction with Kimberly-Clark, competitive pressures, regulatory changes, and economic conditions. Kenvue's management remains focused on executing its strategic priorities and delivering value to its stakeholders, while also navigating the evolving consumer health landscape. The company also announced a restructuring initiative approved by its Board on February 17, 2026, which aims to optimize its operating model, transform its supply chain, reduce complexity, and drive operational efficiencies, while strengthening core capabilities.